BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35867409)

  • 1. High Sensitivity and NPV for BinaxNOW Rapid Antigen Test in Children at a Mass Testing Site during Prevalent Delta Variant Period.
    Sun KJ; Vaeth MJE; Robinson M; Elhabashy M; Gupta I; Purekal S; Hammershaimb EA; Peralta R; Mitchell A; Foyez M; Johnson JK; Ficke JR; Manabe YC; Campbell JD; Callahan CW; Locke CF; Kantsiper M; ; Siddiqui ZK
    Microbiol Spectr; 2022 Aug; 10(4):e0023622. PubMed ID: 35867409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance and Implementation Evaluation of the Abbott BinaxNOW Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts.
    Pollock NR; Jacobs JR; Tran K; Cranston AE; Smith S; O'Kane CY; Roady TJ; Moran A; Scarry A; Carroll M; Volinsky L; Perez G; Patel P; Gabriel S; Lennon NJ; Madoff LC; Brown C; Smole SC
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33622768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge : A Cross-Sectional Study.
    Schrom J; Marquez C; Pilarowski G; Wang CY; Mitchell A; Puccinelli R; Black D; Rojas S; Ribeiro S; Tulier-Laiwa V; Martinez J; Payan J; Rojas S; Jones D; Martinez D; Nakamura R; Chamie G; Jain V; Petersen M; DeRisi J; Havlir D
    Ann Intern Med; 2022 May; 175(5):682-690. PubMed ID: 35286144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation and Accuracy of BinaxNOW Rapid Antigen COVID-19 Test in Asymptomatic and Symptomatic Populations in a High-Volume Self-Referred Testing Site.
    Siddiqui ZK; Chaudhary M; Robinson ML; McCall AB; Peralta R; Esteve R; Callahan CW; Manabe YC; Campbell JD; Johnson JK; Elhabashy M; Kantsiper M; ; Ficke JR
    Microbiol Spectr; 2021 Dec; 9(3):e0100821. PubMed ID: 34851137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of BinaxNOW and SARS-CoV-2 qRT-PCR Detection of the Omicron Variant from Matched Anterior Nares Swabs.
    Landaverde L; Turcinovic J; Doucette-Stamm L; Gonzales K; Platt J; Connor JH; Klapperich C
    Microbiol Spectr; 2022 Dec; 10(6):e0130722. PubMed ID: 36255297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: Implications for screening in a school setting.
    Sood N; Shetgiri R; Rodriguez A; Jimenez D; Treminino S; Daflos A; Simon P
    PLoS One; 2021; 16(4):e0249710. PubMed ID: 33819311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses - Wisconsin, September-October 2020.
    Pray IW; Ford L; Cole D; Lee C; Bigouette JP; Abedi GR; Bushman D; Delahoy MJ; Currie D; Cherney B; Kirby M; Fajardo G; Caudill M; Langolf K; Kahrs J; Kelly P; Pitts C; Lim A; Aulik N; Tamin A; Harcourt JL; Queen K; Zhang J; Whitaker B; Browne H; Medrzycki M; Shewmaker P; Folster J; Bankamp B; Bowen MD; Thornburg NJ; Goffard K; Limbago B; Bateman A; Tate JE; Gieryn D; Kirking HL; Westergaard R; Killerby M;
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 69(5152):1642-1647. PubMed ID: 33382679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Four Point of Care (POC) Antigen Assays for the Detection of the SARS-CoV-2 Variant Omicron.
    Hardick J; Gallagher N; Sachithanandham J; Fall A; Siddiqui Z; Pekosz A; Manabe YC; Mostafa HH
    Microbiol Spectr; 2022 Jun; 10(3):e0102522. PubMed ID: 35616382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance Characteristics of the Abbott BinaxNOW SARS-CoV-2 Antigen Test in Comparison to Real-Time Reverse Transcriptase PCR and Viral Culture in Community Testing Sites during November 2020.
    Almendares O; Prince-Guerra JL; Nolen LD; Gunn JKL; Dale AP; Buono SA; Deutsch-Feldman M; Suppiah S; Hao L; Zeng Y; Stevens VA; Knipe K; Pompey J; Atherstone C; Bui DP; Powell T; Tamin A; Harcourt JL; Petway M; Bohannon C; Folster JM; MacNeil A; Salerno R; Kuhnert-Tallman W; Tate JE; Thornburg N; Kirking HL; Sheiban K; Kudrna J; Cullen T; Komatsu KK; Villanueva JM; Rose DA; Neatherlin JC; Anderson M; Rota PA; Honein MA; Bower WA;
    J Clin Microbiol; 2022 Jan; 60(1):e0174221. PubMed ID: 34705535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of 2 Rapid Antigen Tests During 3 Phases of SARS-CoV-2 Variants.
    Drain PK; Bemer M; Morton JF; Dalmat R; Abdille H; Thomas KK; Uppal TK; Hau D; Green HR; Gates-Hollingsworth MA; AuCoin DP; Verma SC
    JAMA Netw Open; 2022 Aug; 5(8):e2228143. PubMed ID: 36001317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges.
    Schrom J; Marquez C; Wang CY; Saxena A; Mitchell AM; Ribeiro S; Pilarowski G; Nakamura R; Rojas S; Black D; Contreras Oseguera MG; Diaz EC; Payan J; Rojas S; Jones D; Tulier-Laiwa V; Zavaleta A; Martinez J; Chamie G; Glaser C; Jacobson K; Petersen M; DeRisi J; Havlir DV
    PLoS One; 2023; 18(3):e0283576. PubMed ID: 36961855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites - Pima County, Arizona, November 3-17, 2020.
    Prince-Guerra JL; Almendares O; Nolen LD; Gunn JKL; Dale AP; Buono SA; Deutsch-Feldman M; Suppiah S; Hao L; Zeng Y; Stevens VA; Knipe K; Pompey J; Atherstone C; Bui DP; Powell T; Tamin A; Harcourt JL; Shewmaker PL; Medrzycki M; Wong P; Jain S; Tejada-Strop A; Rogers S; Emery B; Wang H; Petway M; Bohannon C; Folster JM; MacNeil A; Salerno R; Kuhnert-Tallman W; Tate JE; Thornburg NJ; Kirking HL; Sheiban K; Kudrna J; Cullen T; Komatsu KK; Villanueva JM; Rose DA; Neatherlin JC; Anderson M; Rota PA; Honein MA; Bower WA
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(3):100-105. PubMed ID: 33476316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Antigen Results Correlate with the Quantity of Replication-Competent SARS-CoV-2 in a Cross-Sectional Study of Ambulatory Adults during the Delta Wave.
    Tu YP; Green C; Hao L; Greninger AL; Morton JF; Sights HA; Gale M; Drain PK
    Microbiol Spectr; 2023 Jun; 11(3):e0006423. PubMed ID: 37097146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting.
    Okoye NC; Barker AP; Curtis K; Orlandi RR; Snavely EA; Wright C; Hanson KE; Pearson LN
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33509809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study.
    Eyre DW; Futschik M; Tunkel S; Wei J; Cole-Hamilton J; Saquib R; Germanacos N; Dodgson AR; Klapper PE; Sudhanva M; Kenny C; Marks P; Blandford E; Hopkins S; Peto TEA; Fowler T
    Lancet Infect Dis; 2023 Aug; 23(8):922-932. PubMed ID: 37001541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Detection Tests Using Oral, Anterior Nasal, and Nasopharyngeal Swabs: a Diagnostic Accuracy Study.
    Wölfl-Duchek M; Bergmann F; Jorda A; Weber M; Müller M; Seitz T; Zoufaly A; Strassl R; Zeitlinger M; Herkner H; Schnidar H; Anderle K; Derhaschnig U
    Microbiol Spectr; 2022 Feb; 10(1):e0202921. PubMed ID: 35107327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Abbott BinaxNOW COVID-19 Test Ag Card for rapid detection of SARS-CoV-2 infection by a local public health district with a rural population.
    Pollreis RE; Roscoe C; Phinney RJ; Malesha SS; Burns MC; Ceniseros A; Washington CH; Nutting AJ; Ball CL
    PLoS One; 2021; 16(12):e0260862. PubMed ID: 34855887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection.
    Bianco G; Boattini M; Barbui AM; Scozzari G; Riccardini F; Coggiola M; Lupia E; Cavallo R; Costa C
    J Clin Virol; 2021 Jun; 139():104838. PubMed ID: 33946040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen Test Performance Among Children and Adults at a SARS-CoV-2 Community Testing Site.
    Ford L; Whaley MJ; Shah MM; Salvatore PP; Segaloff HE; Delaney A; Currie DW; Boyle-Estheimer L; O'Hegarty M; Morgan CN; Meece J; Ivacic L; Thornburg NJ; Tamin A; Harcourt JL; Folster JM; Medrzycki M; Jain S; Wong P; Goffard K; Gieryn D; Kahrs J; Langolf K; Zochert T; Tate JE; Hsu CH; Kirking HL
    J Pediatric Infect Dis Soc; 2021 Dec; 10(12):1052-1061. PubMed ID: 34468732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.